Carlo Russo
Director Técnico/Científico/I+D en GENENTA SCIENCE S.P.A. .
Fortuna: 2 M $ al 31/05/2024
Perfil
Carlo Russo is currently the Chief Medical Officer & Head-Development at Genenta Science SpA since 2021.
Prior to this, he was the President & CEO at VaxInnate Corp.
He also served as the Chief Medical Officer & Executive Vice President at Adverum Biotechnologies, Inc. in 2016.
Dr. Russo holds a doctorate degree from the University of Genoa.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GENENTA SCIENCE SPA
3.28% | 26/03/2024 | 598 417 ( 3.28% ) | 2 M $ | 31/05/2024 |
Cargos activos de Carlo Russo
| Empresas | Cargo | Inicio |
|---|---|---|
| GENENTA SCIENCE S.P.A. | Director Técnico/Científico/I+D | 01/01/2021 |
Antiguos cargos conocidos de Carlo Russo.
| Empresas | Cargo | Fin |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Director Técnico/Científico/I+D | 01/07/2016 |
VaxInnate Corp.
 VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Director Ejecutivo | - |
Formación de Carlo Russo.
| University of Genoa | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| GENENTA SCIENCE S.P.A. | Health Technology |
| Empresas privadas | 1 |
|---|---|
VaxInnate Corp.
VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Carlo Russo
